Autres langues Bio-Thera Solutions, Ltd.

Actions

688177

CNE100003R98

Cours en clôture Shanghai S.E. Autres places de cotation 00:00:00 30/04/2024			Varia. 5j.	Varia. 1 janv.
33,12 ^CNY	-0,51%		+14,21%	-19,69%

29/04	Bio-Thera Solutions, Ltd. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
25/03	Bio-Thera Solutions reçoit l'autorisation de la FDA américaine pour lancer une étude de phase II sur le BAT8006	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Bio-Thera Solutions, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04
Bio-Thera Solutions Receives IND Clearance from US FDA to Initiate a Phase II Study for BAT8006, an Innovative Antibody Drug Conjugate Targeting Folate Receptor	26/03
Bio-Thera Solutions Receives IND Clearance From US FDA to Initiate a Phase II Study for BAT8006	25/03
Bio-Thera Solutions Grants Marketing Rights of Two Drugs to Latin American Company	20/03
Bio-Thera Solutions, Ltd. Partners with SteinCares to Market Two Biosimilars in LATAM	18/03
Bio-Thera Solutions, Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	23/02
Bio-Thera Solutions Announces Initiation of Phase IB / IIA Clinical Trial for BAT6026	01/02
Bio-Thera Solutions Gets Regulatory Nod for Trial of Tumor Drug Combination Treatment	12/01
Recent Biosimilar Approvals	21/12
Sandoz-Partner erhält US-Zulassung für Biosimilar für Roche-Blockbuster	08/12
Bio-Thera Solutions Wins US FDA Nod to Market Cancer Drug	08/12
FDA Approves Bio-Thera Solutions' Avzivi (Bevacizumab-Tnjn), A Biosimilar Referencing Avastin	07/12
Bio-Thera Solutions Announces Positive Results from Phase 3 Study of BAT2206, a Proposed Biosimilar Referencing Stelara	29/11
Bio-Thera Solutions, Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/10/23
Chugai Pharmaceutical Co., Ltd. - Notice of the Settlement of Patent Infringement Litigation in the U.S	25/10/23
Chugai Parent Roche Settles US Lawsuit Against Biogen Over Alleged Biosimilar Infringement	24/10/23
Roche, Biogen Settle US Patent Infringement Case Over Actemra Biosimilar	24/10/23
Roche settles US patent lawsuit against Biogen over blockbuster arthritis drug	23/10/23
Bio-Thera Partner Gets US FDA Marketing Nod for Arthritis Injectable	09/10/23
FDA Approves Bio-Thera Solutions, Ltd.'s Partner Biogen Receives Notification from the United States Food and Drug Administration	08/10/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Bio-Thera Solutions, Ltd.

Actions

688177

CNE100003R98

Autres langues

Filtres